Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
Clinical trial NCT01197170 · COMPLETED
Trial details
- NCT number
- NCT01197170
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-07
- Primary completion
- 2021-01-13
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.